CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
70.69
-1.06 (-1.48%)
Nov 20, 2024, 4:00 PM EST - Market closed
CONMED Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,288 | 1,245 | 1,045 | 1,011 | 862.46 | 955.1 | Upgrade
|
| Revenue Growth (YoY) | 10.23% | 19.06% | 3.45% | 17.18% | -9.70% | 11.11% | Upgrade
|
| Cost of Revenue | 569.15 | 559.9 | 469.73 | 442.6 | 402.16 | 426.19 | Upgrade
|
| Gross Profit | 718.96 | 684.85 | 575.75 | 568.04 | 460.3 | 528.91 | Upgrade
|
| Selling, General & Admin | 516.04 | 504.71 | 439.26 | 414.73 | 374.17 | 388.36 | Upgrade
|
| Research & Development | 55.28 | 52.6 | 47.15 | 43.57 | 40.47 | 45.46 | Upgrade
|
| Operating Expenses | 571.32 | 557.31 | 486.42 | 458.29 | 414.65 | 433.82 | Upgrade
|
| Operating Income | 147.65 | 127.54 | 89.33 | 109.74 | 45.66 | 95.09 | Upgrade
|
| Interest Expense | -37.94 | -39.78 | -28.91 | -35.49 | -44.05 | -42.7 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.65 | 1.65 | -0.56 | -0.05 | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | 111.35 | 89.41 | 59.87 | 74.21 | 1.6 | 52.39 | Upgrade
|
| Merger & Restructuring Charges | -2.9 | -9.4 | -14.6 | - | - | -17.26 | Upgrade
|
| Legal Settlements | - | - | -0.8 | - | - | - | Upgrade
|
| Other Unusual Items | 51.62 | 0.82 | -115.33 | -1.1 | - | -3.9 | Upgrade
|
| Pretax Income | 160.07 | 80.83 | -70.86 | 73.11 | 1.6 | 31.23 | Upgrade
|
| Income Tax Expense | 28.33 | 16.37 | 9.72 | 10.56 | -7.91 | 2.61 | Upgrade
|
| Net Income | 131.74 | 64.46 | -80.58 | 62.54 | 9.52 | 28.62 | Upgrade
|
| Net Income to Common | 131.74 | 64.46 | -80.58 | 62.54 | 9.52 | 28.62 | Upgrade
|
| Net Income Growth | 127.25% | - | - | 557.16% | -66.75% | -29.95% | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 30 | 29 | 29 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 32 | 30 | 32 | 29 | 29 | Upgrade
|
| Shares Change (YoY) | -0.18% | 5.02% | -6.75% | 9.34% | -0.11% | 2.09% | Upgrade
|
| EPS (Basic) | 4.28 | 2.10 | -2.68 | 2.14 | 0.33 | 1.01 | Upgrade
|
| EPS (Diluted) | 4.22 | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 | Upgrade
|
| EPS Growth | 127.53% | - | - | 506.25% | -67.01% | -31.21% | Upgrade
|
| Free Cash Flow | 166.13 | 106.32 | 11.58 | 96.9 | 51.52 | 75.07 | Upgrade
|
| Free Cash Flow Per Share | 5.32 | 3.37 | 0.39 | 3.01 | 1.75 | 2.55 | Upgrade
|
| Dividend Per Share | 0.800 | 0.800 | 0.800 | 0.800 | 0.800 | 0.800 | Upgrade
|
| Gross Margin | 55.81% | 55.02% | 55.07% | 56.21% | 53.37% | 55.38% | Upgrade
|
| Operating Margin | 11.46% | 10.25% | 8.54% | 10.86% | 5.29% | 9.96% | Upgrade
|
| Profit Margin | 10.23% | 5.18% | -7.71% | 6.19% | 1.10% | 3.00% | Upgrade
|
| Free Cash Flow Margin | 12.90% | 8.54% | 1.11% | 9.59% | 5.97% | 7.86% | Upgrade
|
| EBITDA | 217.8 | 197.71 | 156.75 | 177.19 | 113.58 | 162.61 | Upgrade
|
| EBITDA Margin | 16.91% | 15.88% | 14.99% | 17.53% | 13.17% | 17.03% | Upgrade
|
| D&A For EBITDA | 70.15 | 70.17 | 67.42 | 67.44 | 67.93 | 67.52 | Upgrade
|
| EBIT | 147.65 | 127.54 | 89.33 | 109.74 | 45.66 | 95.09 | Upgrade
|
| EBIT Margin | 11.46% | 10.25% | 8.54% | 10.86% | 5.29% | 9.96% | Upgrade
|
| Effective Tax Rate | 17.70% | 20.25% | - | 14.45% | - | 8.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.